Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ultrastructural protein zero expression in Charcot-Marie-Tooth type 1B disease

P Sindou¹, J M Vallat, F Chapon

¹Department of Neurology, University Hospital, Limoges, France.

|January 12, 1999

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Mitochondrial diseases in adults: An update].

La Revue de medecine interne·2021

Same author

Current and emerging therapeutic options for the management of functional dyspepsia.

Expert opinion on pharmacotherapy·2020

Same author

Novel mutations in DNAJB6 cause LGMD1D and distal myopathy in French families.

European journal of neurology·2018

Same author

Combination of acid phosphatase positivity and rimmed vacuoles as useful markers in the diagnosis of adult-onset Pompe disease lacking specific clinical and pathological features.

Folia neuropathologica·2016

Same author

Validation of the Leuven Postprandial Distress Scale, a questionnaire for symptom assessment in the functional dyspepsia/postprandial distress syndrome.

Alimentary pharmacology & therapeutics·2016

Same author

Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2016

Charcot-Marie-Tooth type 1B (CMT 1B) disease involves reduced P0 protein in peripheral nerves. This study found decreased P0 expression in CMT 1B patients, but severity didn't correlate with P0 levels.

Area of Science:

Neuroscience
Genetics
Cell Biology

Background:

Charcot-Marie-Tooth type 1B (CMT 1B) is an inherited demyelinating peripheral neuropathy.
It is caused by point mutations in the P0 gene located on chromosome 1 q21-23.

Observation:

This study quantified P0 protein expression at the ultrastructural level using immunocytochemistry.
P0 expression was analyzed in two unrelated CMT 1B patients with distinct mutations in the P0 gene's extracellular domain.

Findings:

A twofold decrease in P0 protein expression was observed in the compact myelin of both CMT 1B patients compared to controls.
The severity of the clinical phenotypes in these patients did not show a direct correlation with the measured levels of P0 protein expression.

Related Experiment Videos

Implications:

These findings contribute to understanding the molecular mechanisms underlying Charcot-Marie-Tooth type 1B disease.
The lack of correlation between P0 levels and phenotype severity suggests complex disease pathogenesis in CMT 1B.